William Benton Jones Corvus Pharmaceuticals, Inc. (CRVS) insider trading activity
William Benton Jones is of Corvus Pharmaceuticals, Inc.. Currently has a direct ownership of 153,773 shares of CRVS, which is worth approximately $767,327. The most recent transaction as insider was on May 06, 2024, when has been sold 20,000 shares (Common Stock) at a price of $1.73 per share, resulting in proceeds of $34,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
154K
0%
3M change
14.95%
12M change
Total Value Held
$767,327
William Benton Jones Transaction History
WBJ
William Benton Jones
Burlingame, CA